Pain as clinical manifestations of COVID-19 infection and its management in the pandemic era: a literature review
抄録
<jats:title>Abstract</jats:title><jats:p>Coronavirus disease 2019 (COVID-19) is a current global pandemic. The case number has increased since December 31, 2019. It has been reported that COVID-19 patients have been giving pain complaints, one of which is muscular pain. Other types of pain that have also been reported by COVID-19 patients are joint pain, stomach pain, and testicular pain. Neuropathic pain is the rarest case among others. COVID-19 mechanisms in the nerve and musculoskeletal damage are believed to be caused by the expression and distribution of angiotensin-converting enzyme 2 (ACE-2). Patients with pain, especially neuropathic pain, normally do not respond well to various therapies, and experience psychiatric disorders such as depression, which leads to a decrease in the patient’s quality of life. Important considerations for health professionals in terms of pain management during this pandemic include ensuring treatment continuity, painkillers, utilization of telemedicine, biopsychosocial management approach, and modifying therapy needs to reduce the risks of COVID-19 complications.</jats:p>
収録刊行物
-
- The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
-
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery 56 (1), 2020-12
Springer Science and Business Media LLC